Clinical Trial Update: Effect of Finerenone in IgA Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating finerenone for IgA nephropathy is listed as not yet recruiting, with Zhejiang University as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: Zhejiang University | Conditions: IgA Nephropathy | Phase 3 | Status: NOT_YET_RECRUITING